Figure 5.

Immunomodulatory Treatment in Patients with MIS-C

(A) Timelines for individual MIS-C patients (n = 13) indicating date of symptom debut, immunomodulatory treatment regimen, and date of blood sampling. Two patients lacking clinical treatment data were blood sampled prior to treatment.

(B) Volcano plot showing fold-change (post-/pre-treatment) versus p value for 7 patients with multiple samples.

(C) Top markers of treatment response in MIS-C patients. Fold-change pre/post treatment (p < 0.05, false discovery rate [FDR], 1%).

See also Figure S2.